Charles S. Chen, MD

Caritas Norwood HospitalNorwood, Massachusetts - 02062 |
- CLINICAL TRIALS 3
- CONDITIONS3
- INTERVENTIONS22
- SINCE2005

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Placebo
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Study Of Socioeconomic And Demographic Variables
Paclitaxel
Bevacizumab
Cisplatin
Docetaxel
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Pemetrexed Disodium
Doxorubicin Hydrochloride
Polymerase Chain Reaction
Mutation Analysis
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Ac Regimen
Vinorelbine Ditartrate
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique



